Sialic Acid Binding Ig-like Lectin 3
-
Subject Areas on Research
- A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia.
- A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML.
- Alteration of the CD34+ Tf-1 beta cell line profile in response to long-term exposure to IL-15.
- Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin).
- Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia.
- Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
- Diagnosis of posttransplant granulocytic sarcoma by fine-needle aspiration cytology and flow cytometry.
- Effect of APOE and CD33 on Cognitive Decline.
- High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361).
- In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia.